BNP Paribas Financial Markets’s ImageneBio Inc IMA Stock Holding History

BNP Paribas Financial Markets’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142	Hold	24	–	–	﹤0.01%	5776
2026 Q1	$120	Hold	24	–	–	﹤0.01%	5668
2025 Q4	$166	Hold	24	–	–	﹤0.01%	5581
2025 Q3	$196	Sell	24 -2	-8%	-$27	﹤0.01%	5394
2025 Q2	$422	Hold	26	–	–	﹤0.01%	5235
2025 Q1	$403	Sell	26 -3,644	-99%	-$62.9K	﹤0.01%	5157
2024 Q4	$72.2K	Buy	+3,670	New	+$74.2K	﹤0.01%	4293
2022 Q4	–	Sell	-81	Closed	-$3.46K	–	4307
2022 Q3	$3.46K	Buy	+81	New	+$4.68K	﹤0.01%	4286

Other funds holding IMA

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BNP Paribas Financial Markets's IMA Position: Q2 2026 in Review

BNP Paribas Financial Markets held its ImageneBio Inc (IMA) position steady in Q2 2026 at 24 shares worth $142. The position accounts for ﹤0.01% of the portfolio, ranked #5776.

BNP Paribas Financial Markets first reported a position in IMA in Q3 2022 and has held it in 8 quarters since. The position peaked at $72.2K in Q4 2024. 17 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

BNP Paribas Financial Markets held 24 shares of ImageneBio Inc worth $142 as of Q2 2026.
BNP Paribas Financial Markets left its ImageneBio Inc share count unchanged in Q2 2026.
ImageneBio Inc made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5776 holding.
BNP Paribas Financial Markets first reported a position in ImageneBio Inc in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's ImageneBio Inc position peaked at $72.2K in Q4 2024.
17 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.